These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 11207002)
21. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer. Brown J; Thorpe H; Napp V; Fairlamb DJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG; Stephens RJ; Waller D; West P; Peake MD J Clin Oncol; 2005 Oct; 23(30):7417-27. PubMed ID: 16157935 [TBL] [Abstract][Full Text] [Related]
22. [Quality of life as an independent prognostic factor in advanced non-small-cell lung cancer in general practice]. Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Noma S; Iwaki M; Aso H; Sakamoto K; Shimizu J Nihon Kokyuki Gakkai Zasshi; 2006 May; 44(5):368-73. PubMed ID: 16780094 [TBL] [Abstract][Full Text] [Related]
23. Long-term quality of life in inoperable non-small cell lung cancer patients treated with conventionally fractionated compared to hyperfractionated accelerated radiotherapy - Results of the randomized CHARTWEL trial. Hechtner M; Krause M; König J; Appold S; Hornemann B; Singer S; Baumann M Radiother Oncol; 2018 Feb; 126(2):283-290. PubMed ID: 29273262 [TBL] [Abstract][Full Text] [Related]
24. Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab--pooled results from two prospective clinical trials. Hallqvist A; Bergman B; Nyman J Radiother Oncol; 2012 Jul; 104(1):39-44. PubMed ID: 22727262 [TBL] [Abstract][Full Text] [Related]
25. Long-term quality of life in early-stage non-small cell lung cancer patients treated with robotic stereotactic ablative radiation therapy. Mathieu D; Campeau MP; Bahig H; Larrivée S; Vu T; Lambert L; Lavoie C; Roberge D; Doucet R; Carrier JF; Gorgos A; Fortin B; Filion E Pract Radiat Oncol; 2015; 5(4):e365-73. PubMed ID: 25680997 [TBL] [Abstract][Full Text] [Related]
26. [Impact of erlotinib treatment on symptoms and quality of life in patients with advanced non-small-cell lung cancer]. Zhou SW; Ren SX; Yan LH; Zhang L; Zhou CC Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):469-72. PubMed ID: 19024526 [TBL] [Abstract][Full Text] [Related]
27. High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL. Pijls-Johannesma M; Houben R; Boersma L; Grutters J; Seghers K; Lambin P; Wanders R; De Ruysscher D Radiother Oncol; 2009 Jun; 91(3):443-8. PubMed ID: 19297049 [TBL] [Abstract][Full Text] [Related]
28. Quality of life and related factors in patients with newly diagnosed advanced lung cancer: a longitudinal study. Liao YC; Shun SC; Liao WY; Yu CJ; Yang PC; Lai YH Oncol Nurs Forum; 2014 Mar; 41(2):E44-55. PubMed ID: 24578085 [TBL] [Abstract][Full Text] [Related]
29. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Langendijk H; de Jong J; Tjwa M; Muller M; ten Velde G; Aaronson N; Lamers R; Slotman B; Wouters M Radiother Oncol; 2001 Mar; 58(3):257-68. PubMed ID: 11230886 [TBL] [Abstract][Full Text] [Related]
30. Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer. van der Voort van Zyp NC; Prévost JB; van der Holt B; Braat C; van Klaveren RJ; Pattynama PM; Levendag PC; Nuyttens JJ Int J Radiat Oncol Biol Phys; 2010 May; 77(1):31-7. PubMed ID: 19864077 [TBL] [Abstract][Full Text] [Related]
31. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Bergman B; Aaronson NK; Ahmedzai S; Kaasa S; Sullivan M Eur J Cancer; 1994; 30A(5):635-42. PubMed ID: 8080679 [TBL] [Abstract][Full Text] [Related]
32. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. Hopwood P; Stephens RJ J Clin Oncol; 2000 Feb; 18(4):893-903. PubMed ID: 10673533 [TBL] [Abstract][Full Text] [Related]
33. Quality of life following lung cancer resection: video-assisted thoracic surgery vs thoracotomy. Li WW; Lee TW; Lam SS; Ng CS; Sihoe AD; Wan IY; Yim AP Chest; 2002 Aug; 122(2):584-9. PubMed ID: 12171836 [TBL] [Abstract][Full Text] [Related]
34. Impact of pre-radiation therapy quality of life in lung cancer survival: a prospective, intention-to-treat, multicenter study. Nieto-Guerrero Gómez JM; Silva Vega GP; Cacicedo J; Delgado León BD; Herrero Rivera D; Praena Fernández JM; Rivin Del Campo E; Ortiz Gordillo MJ; López Guerra JL Clin Transl Oncol; 2020 Sep; 22(9):1635-1644. PubMed ID: 32072471 [TBL] [Abstract][Full Text] [Related]
35. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group. J Natl Cancer Inst; 1999 Jan; 91(1):66-72. PubMed ID: 9890172 [TBL] [Abstract][Full Text] [Related]
36. Changes in and Determinants of Quality of Life in Patients With Advanced Non-Small-Cell Lung Cancer Undergoing Initial Chemotherapy. Dai YL; Yang CT; Chen KH; Tang ST J Nurs Res; 2017 Jun; 25(3):203-215. PubMed ID: 28481816 [TBL] [Abstract][Full Text] [Related]
37. Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group. Auchter RM; Scholtens D; Adak S; Wagner H; Cella DF; Mehta MP Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1199-206. PubMed ID: 11483329 [TBL] [Abstract][Full Text] [Related]
38. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale. Gebbia V; Lorusso V; Galetta D; Caruso M M; Palomba G; Riccardi F; Borsellino N; Carrozza F; Leo S; Ferraù F; Cinieri S; Mancuso G; Mancarella S; Colucci G Lung Cancer; 2010 Aug; 69(2):218-24. PubMed ID: 19910076 [TBL] [Abstract][Full Text] [Related]
39. Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer. Si X; Zhang L; Wang H; Zhang X; Wang M; Han B; Li K; Wang Q; Shi J; Wang Z; Cheng Y; He J; Shi Y; Chen W; Wang X; Luo Y; Nan K; Jin F; Li B; Chen Y; Zhou J; Wang D Lung Cancer; 2018 Aug; 122():32-37. PubMed ID: 30032842 [TBL] [Abstract][Full Text] [Related]
40. Health-related quality of life in long-term survivors of unresectable locally advanced non-small cell lung cancer. Ran J; Wang J; Bi N; Jiang W; Zhou Z; Hui Z; Liang J; Feng Q; Wang L Radiat Oncol; 2017 Dec; 12(1):195. PubMed ID: 29197373 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]